Production of IL‐27 in multiple sclerosis lesions by astrocytes and myeloid cells: Modulation of local immune responses
Abstract
The mechanisms whereby human glial cells modulate local immune responses are not fully understood. Interleukin‐27 (IL‐27), a pleiotropic cytokine, has been shown to dampen the severity of experimental autoimmune encephalomyelitis, but it is still unresolved whether IL‐27 plays a role in the human disease multiple sclerosis (MS). IL‐27 contribution to local modulation of immune responses in the brain of MS patients was investigated. The expression of IL‐27 subunits (EBI3 and p28) and its cognate receptor IL‐27R (the gp130 and TCCR chains) was elevated within post‐mortem MS brain lesions compared with normal control brains. Moreover, astrocytes (GFAP+ cells) as well as microglia and macrophages (Iba1+ cells) were important sources of IL‐27. Brain‐infiltrating CD4 and CD8 T lymphocytes expressed the IL‐27R specific chain (TCCR) implying that these cells could respond to local IL‐27 sources. In primary cultures of human astrocytes inflammatory cytokines increased IL‐27 production, whereas myeloid cell inflammatory M1 polarization and inflammatory cytokines enhanced IL‐27 expression in microglia and macrophages. Astrocytes in postmortem tissues and in vitro expressed IL‐27R. Moreover, IL‐27 triggered the phosphorylation of the transcription regulator STAT1, but not STAT3 in human astrocytes; indeed IL‐27 up‐regulated MHC class I expression on astrocytes in a STAT1‐dependent manner. These findings demonstrated that IL‐27 and its receptor were elevated in MS lesions and that local IL‐27 can modulate immune properties of astrocytes and infiltrating immune cells. Thus, therapeutic strategies targeting IL‐27 may influence not only peripheral but also local inflammatory responses within the brain of MS patients. GLIA 2016;64:553–569Keywords
Funding Information
- Discovery grant from the Natural Sciences and Engineering Research (NSERC-355722)
- Operating grant from the Multiple Sclerosis Society of Canada (MSSOC)
This publication has 101 references indexed in Scilit:
- IL-27 increases BST-2 expression in human monocytes and T cells independently of type I IFNScientific Reports, 2012
- Persistent loss of IL-27 responsiveness in CD8+ memory T cells abrogates IL-10 expression in a recall responseProceedings of the National Academy of Sciences, 2012
- Cytokine-Like Factor 1 Gene Expression Is Enriched in Idiopathic Pulmonary Fibrosis and Drives the Accumulation of CD4+ T Cells in Murine LungsThe American Journal of Pathology, 2012
- Toll‐like receptor 2 (TLR2)‐TLR9 crosstalk dictates IL‐12 family cytokine production in microgliaGlia, 2011
- Signaling Events Involved in Interleukin 27 (IL-27)-induced Proliferation of Human Naive CD4+ T Cells and B CellsJournal of Biological Chemistry, 2011
- The Immunopathophysiology of Multiple SclerosisNeurologic Clinics, 2011
- Interleukin-27 Induces a STAT1/3- and NF-κB-dependent Proinflammatory Cytokine Profile in Human MonocytesJournal of Biological Chemistry, 2010
- Molecular basis of oncostatin M‐induced SOCS‐3 expression in astrocytesGlia, 2008
- TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1Nature Medicine, 2007
- Regulation of IL-27 p28 gene expression in macrophages through MyD88- and interferon-γ–mediated pathwaysJournal of Experimental Medicine, 2007